Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Taguchi

Showing results (131-140 of 154) with videos related to

Pageof 16
Sort By:
JCO Precision Oncology|January 17, 2025
Actionable Gene Alterations Identified in Patients With Malignant Melanoma by Targeted Sequencing in JapanTakuro Noguchi, Shin Ariga, Rika Moku, et al.
Leukemia Research|December 27, 2014
Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapyYuki Nakajima, Naoto Tomita, Megumi Itabashi, et al.
International Journal of Hematology|April 10, 2019
Impact of treatment-related weight changes from diagnosis to hematopoietic stem-cell transplantation on clinical outcome of acute myeloid leukemiaTaiki Ando, Shin Fujisawa, Haruka Teshigawara, et al.
Cancer|April 21, 2026
Objective response rate predicts survival in recurrent or metastatic head and neck squamous cell carcinoma treated with immune checkpoint blockade but not with targeted therapy: A retrospective multicenter studyTakahiro Inoue, Michihisa Kono, Takumi Kumai, et al.
Leukemia & Lymphoma|June 11, 2014
Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisoneNaoto Tomita, Hirotaka Takasaki, Yasufumi Ishiyama, et al.
Leukemia Research|April 14, 2015
R-CHOP therapy alone for limited-stage follicular lymphomaNaoto Tomita, Taisei Suzuki, Yasufumi Ishiyama, et al.
Frontiers in Oncology|May 17, 2024
Clinical outcomes for olfactory neuroblastomaAkira Nakazono, Hiroaki Motegi, Masanobu Suzuki, et al.
British Journal of Haematology|February 26, 2013
R-CHOP therapy alone in limited stage diffuse large B-cell lymphomaNaoto Tomita, Hirotaka Takasaki, Kazuho Miyashita, et al.
British Journal of Haematology|December 22, 2017
Chromosomal analysis of myelodysplastic syndromes among atomic bomb survivors in NagasakiMakiko Horai, Shinya Satoh, Masatoshi Matsuo, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 15, 2015
[Analysis of prognostic factors in transplant-eligeble newly diagnosed myeloma patients treated with bortezomib plus dexamethasone as induction therapy]Hideyuki Koharazawa, Reina Watanabe, Yukako Hattori, et al.
Pageof 16

Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
JCO Precision Oncology|January 17, 2025
Actionable Gene Alterations Identified in Patients With Malignant Melanoma by Targeted Sequencing in JapanTakuro Noguchi, Shin Ariga, Rika Moku, et al.
Leukemia Research|December 27, 2014
Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapyYuki Nakajima, Naoto Tomita, Megumi Itabashi, et al.
International Journal of Hematology|April 10, 2019
Impact of treatment-related weight changes from diagnosis to hematopoietic stem-cell transplantation on clinical outcome of acute myeloid leukemiaTaiki Ando, Shin Fujisawa, Haruka Teshigawara, et al.
Cancer|April 21, 2026
Objective response rate predicts survival in recurrent or metastatic head and neck squamous cell carcinoma treated with immune checkpoint blockade but not with targeted therapy: A retrospective multicenter studyTakahiro Inoue, Michihisa Kono, Takumi Kumai, et al.
Leukemia & Lymphoma|June 11, 2014
Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisoneNaoto Tomita, Hirotaka Takasaki, Yasufumi Ishiyama, et al.
Leukemia Research|April 14, 2015
R-CHOP therapy alone for limited-stage follicular lymphomaNaoto Tomita, Taisei Suzuki, Yasufumi Ishiyama, et al.
Frontiers in Oncology|May 17, 2024
Clinical outcomes for olfactory neuroblastomaAkira Nakazono, Hiroaki Motegi, Masanobu Suzuki, et al.
British Journal of Haematology|February 26, 2013
R-CHOP therapy alone in limited stage diffuse large B-cell lymphomaNaoto Tomita, Hirotaka Takasaki, Kazuho Miyashita, et al.
British Journal of Haematology|December 22, 2017
Chromosomal analysis of myelodysplastic syndromes among atomic bomb survivors in NagasakiMakiko Horai, Shinya Satoh, Masatoshi Matsuo, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 15, 2015
[Analysis of prognostic factors in transplant-eligeble newly diagnosed myeloma patients treated with bortezomib plus dexamethasone as induction therapy]Hideyuki Koharazawa, Reina Watanabe, Yukako Hattori, et al.
Pageof 16